Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin resistance or variable response or both?

Xi Cheng1, Wai-Hong Chen, Daniel I Simon

  • 1Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.

The American Journal of Cardiology
|November 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incremental prognostic value of coronary artery calcium progression within a large community-benefit calcium score registry.

American journal of preventive cardiology·2026
Same author

Sex-Based Outcomes in Patients With High Bleeding Risk After PCI With 1-Month DAPT: Results From the Onyx ONE Clear Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Steroidal versus Non-steroidal Mineralocorticoid Receptor Antagonists in Heart failure with Preserved Ejection Fraction: A Propensity-Matched Multi-Network Nationwide Cohort Study.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Kindlin-3 phosphorylation is crucial for thrombosis and hemostasis <i>in vivo</i>.

Research and practice in thrombosis and haemostasis·2025
Same author

Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era.

US cardiology·2024
Same author

Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Aspirin resistance, a phenomenon where patients do not respond effectively to aspirin therapy, requires further research. Understanding the mechanisms and defining resistance are crucial for optimizing cardiovascular event prevention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Platelet Biology

Background:

  • Aspirin is widely used for cardiovascular event prevention.
  • Some patients exhibit reduced or absent response to aspirin, termed aspirin resistance.
  • The mechanisms underlying aspirin resistance are not fully understood.

Purpose of the Study:

  • To explore the concept and mechanisms of aspirin resistance.
  • To highlight the need for standardized definitions and diagnostic criteria.
  • To review ongoing research and clinical trials investigating aspirin resistance.

Main Methods:

  • Review of existing clinical and laboratory evidence.
  • Discussion of ongoing and completed prospective randomized trials (CHARISMA, ASCET, RESISTOR).

Related Experiment Videos

  • Emphasis on the need for large-scale population studies with consistent assays.

    • Main Results:

    • Aspirin resistance is a poorly defined clinical concept.
    • Mechanisms likely involve a combination of clinical, biological, and genetic factors affecting platelet function.
    • No consensus exists on defining aspirin resistance (clinical outcomes vs. laboratory evidence).

    Conclusions:

    • Further research is needed to establish clear criteria for aspirin resistance.
    • Standardized assays and large population studies are essential to correlate laboratory findings with clinical outcomes.
    • Optimizing antiplatelet therapy requires a better understanding of individual patient responses.